Literature DB >> 27402875

Muscle-specific androgen receptor deletion shows limited actions in myoblasts but not in myofibers in different muscles in vivo.

Kesha Rana1, Maria W S Chiu2, Patricia K Russell2, Jarrod P Skinner2, Nicole K L Lee2, Barbara C Fam2, Jeffrey D Zajac2, Helen E MacLean2.   

Abstract

The aim of this study was to investigate the direct muscle cell-mediated actions of androgens by comparing two different mouse lines. The cre-loxP system was used to delete the DNA-binding activity of the androgen receptor (AR) in mature myofibers (MCK mAR(ΔZF2)) in one model and the DNA-binding activity of the AR in both proliferating myoblasts and myofibers (α-actin mAR(ΔZF2)) in another model. We found that hind-limb muscle mass was normal in MCK mAR(ΔZF2) mice and that relative mass of only some hind-limb muscles was reduced in α-actin mAR(ΔZF2) mice. This suggests that myoblasts and myofibers are not the major cellular targets mediating the anabolic actions of androgens on male muscle during growth and development. Levator ani muscle mass was decreased in both mouse lines, demonstrating that there is a myofiber-specific effect in this unique androgen-dependent muscle. We found that the pattern of expression of genes including c-myc, Fzd4 and Igf2 is associated with androgen-dependent changes in muscle mass; therefore, these genes are likely to be mediators of anabolic actions of androgens. Further research is required to identify the major targets of androgen actions in muscle, which are likely to include indirect actions via other tissues.
© 2016 Society for Endocrinology.

Entities:  

Keywords:  androgen receptor; muscle; myoblasts; myofibers

Mesh:

Substances:

Year:  2016        PMID: 27402875     DOI: 10.1530/JME-15-0320

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  7 in total

1.  Disruptions to the limb muscle core molecular clock coincide with changes in mitochondrial quality control following androgen depletion.

Authors:  Michael L Rossetti; Karyn A Esser; Choogon Lee; Robert J Tomko; Alexey M Eroshkin; Bradley S Gordon
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-07-30       Impact factor: 4.310

2.  Myocytic androgen receptor overexpression does not affect sex differences in adaptation to chronic endurance exercise.

Authors:  Sabrina Tzivia Barsky; Douglas Ashley Monks
Journal:  Biol Sex Differ       Date:  2022-10-23       Impact factor: 8.811

Review 3.  The role of the androgen receptor in the pathogenesis of obesity and its utility as a target for obesity treatments.

Authors:  Varun S Venkatesh; Mathis Grossmann; Jeffrey D Zajac; Rachel A Davey
Journal:  Obes Rev       Date:  2022-01-27       Impact factor: 10.867

4.  Myofiber androgen receptor increases muscle strength mediated by a skeletal muscle splicing variant of Mylk4.

Authors:  Iori Sakakibara; Yuta Yanagihara; Koichi Himori; Takashi Yamada; Hiroshi Sakai; Yuichiro Sawada; Hirotaka Takahashi; Noritaka Saeki; Hiroyuki Hirakawa; Atsushi Yokoyama; So-Ichiro Fukada; Tatsuya Sawasaki; Yuuki Imai
Journal:  iScience       Date:  2021-03-13

5.  Sex differences in metabolic pathways are regulated by Pfkfb3 and Pdk4 expression in rodent muscle.

Authors:  Antonius Christianto; Takashi Baba; Fumiya Takahashi; Kai Inui; Miki Inoue; Mikita Suyama; Yusuke Ono; Yasuyuki Ohkawa; Ken-Ichirou Morohashi
Journal:  Commun Biol       Date:  2021-11-04

6.  MiRNA sequencing of Embryonic Myogenesis in Chengkou Mountain Chicken.

Authors:  Jun'an Shi; Wendong Li; Anfang Liu; Lingtong Ren; Pusen Zhang; Ting Jiang; Yuqing Han; Lingbin Liu
Journal:  BMC Genomics       Date:  2022-08-10       Impact factor: 4.547

7.  11βHSD1 Inhibition with AZD4017 Improves Lipid Profiles and Lean Muscle Mass in Idiopathic Intracranial Hypertension.

Authors:  Rowan S Hardy; Hannah Botfield; Keira Markey; James L Mitchell; Zerin Alimajstorovic; Connar S J Westgate; Michael Sagmeister; Rebecca J Fairclough; Ryan S Ottridge; Andreas Yiangou; Karl-Heinz H Storbeck; Angela E Taylor; Lorna C Gilligan; Wiebke Arlt; Paul M Stewart; Jeremy W Tomlinson; Susan P Mollan; Gareth G Lavery; Alexandra J Sinclair
Journal:  J Clin Endocrinol Metab       Date:  2021-01-01       Impact factor: 5.958

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.